1369357-99-2
Chemical Structure
ALS-I-41
- CAS 番号: 1369357-99-2
- Formula:C30H38FN3O6S
- Molecular Weight:587.70
IUPAC Name: 1-(1-(2-(2-(2-fluoroethoxy)-4-((1-(methylsulfonyl)piperidin-4-yl)oxy)phenyl)acetyl)piperidin-4-yl)-3,4-dihydroquinolin-2(1H)-one
InChIKey: SYRRIFTXJYXCIX-UHFFFAOYSA-N
SMILES: O=C1N(C2CCN(CC2)C(CC3=CC=C(C=C3OCCF)OC4CCN(S(=O)(C)=O)CC4)=O)C5=C(CC1)C=CC=C5
Biological Activity: ALS-I-41 is a novel, potent and selective oxytocin receptor antagonist with the potential to modulate biological activities related to social behavior and mental disorders. ALS-I-41 is being evaluated for behavioral pharmacology experiments in non-human primates and can be administered via intranasal or intramuscular injection. The central nervous system penetration and metabolic rate of ALS-I-41 were studied by mass spectrometry analysis in cerebrospinal fluid and plasma of macaque monkeys[1].
| 製品番号 | 製品名 | 純度 | 製品説明 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ALS-I-41 | ALS-I-41 is a novel, potent and selective oxytocin receptor antagonist with the potential to modulate biological activities related to social behavior and mental disorders. ALS-I-41 is being evaluated for behavioral pharmacology experiments in non-human primates and can be administered via intranasal or intramuscular injection. The central nervous system penetration and metabolic rate of ALS-I-41 were studied by mass spectrometry analysis in cerebrospinal fluid and plasma of macaque monkeys. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
